Biogen
Why R&D must digitalize and become data-centric
April 08 by Leila Hawkins
Find out why digital transformation and the cloud are essential tools for R&D companies today in this report by Pharma IQ produced with Benchling
FDA grants accelerated approval for first Alzheimer’s disease treatment
June 11 by Emily Uwemedimo
The FDA has approved Biogen and Eisai’s Alzheimer’s disease drug aducanumab
Top 10 Pharma Companies: Who's Recruiting?
June 01 by Pharmaceuticals & Biotechnology EditorAs the Pharmaceutical industry continues to grow, many have asked where the upcoming investments will take place?In response to this, the Pharma IQ team has conducted some research and compiled...
